Bionano Genomics Inc. is a life sciences instrumentation company specializing in decoding the genome for biomedical research, diagnostics, and personalized medicine applications. The company's primary focus is its proprietary Saphyr system, an advanced platform designed to analyze the structural variations of DNA on a large scale. This system supports researchers and clinicians in detecting genetic diseases, cancer-causing mutations, and other genomic variations that traditional sequencing methods may overlook. Bionano Genomics' technology offers high throughput and resolution, making it an invaluable tool in genomics labs and research institutions. The company's contributions are pivotal in the fields of genetic research and diagnostics, where precise insights into the genome pave the way for breakthroughs in understanding complex genetic disorders. By facilitating a deeper comprehension of the human genome, Bionano Genomics plays a crucial role in advancing genomic medicine and improving patient outcomes through more personalized and effective therapies.